Nucleolar protein NOC4L inhibits tumorigenesis and progression by attenuating SIRT1-mediated p53 deacetylation

Area of Science:

• Molecular Biology
• Cancer Research
• Cellular Stress Response

Background:

• SIRT1, an NAD+-dependent deacetylase, is upregulated in various tumors, contributing to tumorigenesis and progression.
• The precise mechanisms by which SIRT1 influences cancer remain incompletely understood.
• Nucleolar stress is implicated in cellular responses to damage and disease.

Purpose of the Study:

• To identify novel regulators of SIRT1 activity in the context of cancer.
• To elucidate the role of the nucleolar protein NOC4L in SIRT1-mediated signaling.
• To investigate the impact of NOC4L on p53 acetylation, cell apoptosis, and tumor growth.

Main Methods:

• Co-immunoprecipitation assays to confirm NOC4L-SIRT1 interaction in vitro and in various cell types under nucleolar stress.
• Site-directed mutagenesis to identify the domains of NOC4L and SIRT1 involved in their interaction.
• Western blotting to assess p53 acetylation levels and protein expression of SIRT1, p53, and NOC4L.
• Cell proliferation assays and nude mice xenograft models to evaluate tumor growth inhibition.
• Clinical correlation analysis of NOC4L expression with patient survival in colorectal cancer, stratified by TP53 mutation status.

Main Results:

• NOC4L directly binds to SIRT1, particularly under nucleolar stress, with interaction dependent on NOC4L's C-terminus and SIRT1's catalytic domain.
• Overexpression of NOC4L increases p53 acetylation and promotes apoptosis without altering SIRT1 or p53 protein levels.
• NOC4L inhibits tumor cell proliferation and growth in vivo in a p53-dependent manner.
• High NOC4L expression is associated with improved prognosis in colorectal cancer patients with wild-type TP53.

Conclusions:

• NOC4L acts as a novel inhibitor of SIRT1, modulating p53 acetylation and influencing tumor suppression.
• The findings reveal a new molecular mechanism by which nucleolar protein NOC4L regulates p53 under nucleolar stress.
• This research offers insights into tumorigenesis and cellular self-protection during early-stage DNA damage, highlighting NOC4L as a potential therapeutic target.